Pro Test Diagnostics has developed a routine test to monitor and detect illegal use of one’s own stored blood to enhance performance in elite athletes. The ABT™-test can expose athletes who have used blood doping and the result is not affected by the athlete’s training intensity, the use of high-altitude training or the use of low oxygen tents.
We are developing a targeted mass-spectrometry biomarker tool for differentiating subgroups of patients with Parkinsonian disorders exhibiting similar clinical symptoms but having distinct molecular etiologies of neurological disease.
By combining two different methods, Medsens AB aimed to offer a whole new tool for realtime microdiagnostics during prostate cancer surgery. Medsens, based on the work of Olof Lindahl och Kerstin Ramser, received support from UBI for three years. The company is put on hold but the research is ongoing.
HiloProbe was a research-based company in the field of cancer diagnostics. HiloProbe developed ColoNode® – a biomarker test for the accurate detection and characterization of cancer cells in the lymph nodes of colorectal cancer patients. At the beginning of 2025, HiloProbe shut down its operations.